Biotech News: Mirror to Biotech Academia & Industry

Biotech news from India and across the globe. One stop site for your daily dose of Biotech industry , academia news and latest collaborations

A first-of-its-kind implant to treat obesity that curbs appetite by electrically stimulating stomach ne8rves has been approved in the US.

In a first, an Indian-origin researcher from the University of Manchester has created a biosensor that can help machines smell the way humans do. The new gen

The Biotechnology Industry Research Assistance Council (BIRAC) has invited research proposals from biotechnology start-ups and entrepreneurs having a registered company incorporated on or after Jan

A new study conducted in twins has suggested that the major role in determining the state of our immune system is played by the environment, more than our heredity.

The BJP government's 'Make in India' initiative could get top billing in the 2015-16 Union Budget with tax breaks and other measures for several sectors.

Cash rained down on startups in 2014, as venture capitalists poured a whopping $48.3 billion into new US companies - levels not seen since before the dot-com bubble burst in 2001.

Engineers at the University of California, San Diego have developed a flexible temporary tattoo that can detect glucose levels without painful finger pricks – a promising step in non-evasive

The Government allows the private manufacturers of bio-diesel to sell it directly to consumers in a bid to augment supply of environmental friendly fuel.

Optical lenses for glaucoma are quite common, but a biodegradable lens that helps administer medicine with higher efficiency is in the making.

Personal genetics testing works like this: you spit in a tube, mail it away to a company like 23andMe, and for less than $100, get back a read out on your biological relatives, ancestry (lineage an

Piramal Enterprises' Pharma Solution division, a global leader in contract development and manufacturing today said it plans to invest USD 40 million in new equipment and next generation techno

The European Union agreed to let its national governments go their own way on the cultivation of genetically modified crops in a bid to end years of regulatory gridlock that fueled trans-Atlantic t

Biotecnika Magazine: Jan 2015 edition

Need for high investment, lack of necessary facilities and the complex nature of the virus make the finding of a vaccine for Ebola a difficult challenge.

Bio-pharmaceutical company Celestial Biolabs is all set to launch an antibiotic product for the treatment of diabetes.

It's a breakthrough in cancer care — make cancer cells glow inside the body and hit them hard.

In a massive breakthrough, scientists have created the first new antibiotic in more than three decades, Teixobactin, that can treat many common bacterial infections such as tuberculosis, septicemia

The 10th and final leg of the Thermo Fisher Scientific’s Asia Pacific and Japan Genetic Solutions World Tour, kicked off in Mumbai India on 24th November.

Nestlé Health Science announced that it has invested $65 million in Seres Health, a start-up based in Cambridge, Mass., that focuses on restoring the “microbiome” — the hos

Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva as CEO of Jubilant Pharma, a wholly-owned subsidiary of the pharmaceutical company.

Researchers at Université Laval's Faculty of Science and Engineering and Centre for Optics, Photonics and Lasers have developed smart textiles able to monitor and transmit wearers' b

Johnson & Johnson announced the start of a phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

Biotecnika Magazine brings to you...


Moderna Therapeutics, a biotechnology company in Cambridge, Mass., announced that it has raised $450 million from investors including Viking Global Investors LP, Invus, RA Capital Management, and W